TWFG:NASDAQTWFG, Inc. Analysis
Data as of 2026-06-22 - not real-time
$21.67
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TWFG is trading at $21.67, comfortably above its 20‑day (≈$19.96) and 50‑day (≈$19.36) simple moving averages, while still sitting below the 200‑day average of $23.33, indicating a short‑term bullish bias within a longer‑term neutral framework. Technical momentum is reinforced by a bullish MACD histogram (+$0.19) and an RSI of 62.6, suggesting the stock has upward thrust but is approaching overbought territory. The share price reflects a high implied volatility of over 43% on a 30‑day basis, yet the beta of –0.22 points to a low correlation with broader market moves, offering a potential defensive edge.
Fundamentally, TWFG posted a 35% revenue surge to $267.5 M, maintains an impressive 85% gross margin and a 16.9% operating margin, and generates $60.6 M of operating cash flow against modest debt of $8.5 M. Despite a trailing P/E of 38.7—well above the industry average of 16.9—the forward P/E contracts to 19.6, and a DCF‑derived fair value of $126.4 suggests substantial upside, albeit with a modest 8.8% upside/downside estimate. The company’s participation in the William Blair Growth Stock Conference underscores growing investor interest, while the absence of a dividend confirms a reinvest‑focused growth strategy.
Fundamentally, TWFG posted a 35% revenue surge to $267.5 M, maintains an impressive 85% gross margin and a 16.9% operating margin, and generates $60.6 M of operating cash flow against modest debt of $8.5 M. Despite a trailing P/E of 38.7—well above the industry average of 16.9—the forward P/E contracts to 19.6, and a DCF‑derived fair value of $126.4 suggests substantial upside, albeit with a modest 8.8% upside/downside estimate. The company’s participation in the William Blair Growth Stock Conference underscores growing investor interest, while the absence of a dividend confirms a reinvest‑focused growth strategy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term SMAs and bullish MACD
- High 30‑day volatility and approaching overbought RSI
- Low beta reducing market‑wide downside exposure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong 35% revenue growth and high gross margin
- Forward P/E compression and DCF upside potential
- Increased visibility from conference presentation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Durable insurance brokerage model with diversified product suite
- Robust operating cash flow and minimal debt load
- Undervalued relative to growth prospects despite high trailing multiples
Key Metrics & Analysis
Financial Health
Revenue Growth35.30%
Profit Margin3.13%
P/E Ratio38.7
ROE16.16%
ROA7.77%
Debt/Equity2.78
P/B Ratio4.4
Op. Cash Flow$60.6M
Free Cash Flow$-42008500
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI62.6
Support$17.90
Resistance$22.25
MA 20$19.96
MA 50$19.36
MA 200$23.33
MACDBullish
VolumeStable
Fear & Greed Index91.14
Valuation
Fair Value$126.43
Target Price$23.57
Upside/Downside8.77%
GradeFair
TypeBlend
Risk Assessment
Beta-0.22
Volatility43.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.